We are live on ! Find out more
TMCI icon

Treace Medical Concepts

132 hedge funds and large institutions have $538M invested in Treace Medical Concepts in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $4.22M | Put options by funds: $1.78M

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

4% more funds holding

Funds holding: 127132 (+5)

3% more capital invested

Capital invested by funds: $523M → $538M (+$15.1M)

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

0.37% more ownership

Funds ownership: 66.49%66.86% (+0.37%)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
132
Holders Change
+5
Holders Change %
+3.94%
% of All Funds
1.9%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
19
Increased
48
Reduced
47
Closed
14
Calls
$4.22M
Puts
$1.78M
Net Calls
+$2.45M
Net Calls Change
+$3.96M

TMCI Hedge Fund Activity: Q1 2024 in Review

132 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q1 2024, worth a combined $538M — up 2.9% from $523M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TMCI positions and 14 closed out — a net gain of 5 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Millennium Management, adding an estimated $18.1M. The largest seller was Divisadero Street Capital Management, cutting an estimated $21.8M.

  • 132 institutional investors held Treace Medical Concepts (TMCI) as of Q1 2024, up from 127 in Q4 2023.
  • Funds reported $538M of Treace Medical Concepts stock for Q1 2024, up 2.9% quarter-over-quarter.
  • 19 funds opened new Treace Medical Concepts positions in Q1 2024 and 14 closed out, a net change of +5 holders.
  • The largest Treace Medical Concepts buyer in Q1 2024 was Millennium Management, an estimated $18.1M added.
  • The largest Treace Medical Concepts seller in Q1 2024 was Divisadero Street Capital Management, an estimated $21.8M sold.

Based on aggregated 13F filings for Q1 2024.